Grant: Strategic Projects - Group
University of Victoria
$152,000.00
Manufacturing Block Copolymer-Based Drug Delivery Vehicles in Microfluidics
EF 2013-14
Résumé
The loading of certain therapeutics into lipid- or polymer-based drug delivery vehicles is critical to theirsuccessful administration. Drug delivery vehicles increase efficacy for both water-soluble (e.g. the anticancer drug doxorubicin) and water-insoluble (e.g. the anticancer drug paclitaxel) drugs by controlling release and optimizing dosage over a long period of time, or by targeting specific tissues where high dosages are required. Critical figures of merit for drug delivery systems are: 1) the shape, size, and size uniformity of drug carriers, which have a strong effect on circulation times and bio-distribution, and 2) the loading levels and efficiencies for various drug types. In partnership with Northern Lipids Inc and Cardiome Pharma Corp, the proposed work will develop new microfluidic manufacturing platforms for the formation and loading of block copolymer-based drug delivery vehicles. This work leverages recent findings of the Moffitt-Sinton collaboration at the University of Victoria and the University of Toronto. The applicants discovered that localized high-shear regions within multiphase reactors promote particle break-up in addition to morphology changes, providing a new ""top-down"" handle for controlling self-assembly in microfluidic systems. The microfluidic systems to be developed here will incorporate these high shear forces in combination with fast mixing and tailored drug injection strategies, to enable simultaneous self-assembly and loading of block copolymer-based drug delivery vehicles. The approach is expected to provide improved control over shape, size, size uniformity, and drug loading, leading to increased health benefits at lower cost. This proposal addresses the ""Manufacturing"" strategic target area, and most specifically the research topic ""(a) Material Systems"". Within that topic, this work focuses on a unique intersection of chemical (self-assembly) and microfluidic (shear, mixing) production control, in order to enable new manufacturing processes for drug delivery nanomaterials with improved functional performance. An important output of the project is the training of highly qualified personnel for the pharmaceutical, instrumentation, and microsystems sectors.
Programme
Strategic Projects - Group
Bénéficiaire
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
447332-2013
Name nom
Moffitt, Matthew
Department département
Chemistry
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
152000
Program id
STPGP
Program name en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1569
Committee name en
Strategic Projects Selection Panel - Manufacturing
Committee name fr
Comité de sélection des projets stratégiques - Fabrication
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
3754
Research subject group en
Polymer chemistry
Research subject group fr
Chimie des polymères
Research subject en
Biopolymers
Research subject fr
Biopolymères
Partie
1
Nb partie
3
Application title
Manufacturing Block Copolymer-Based Drug Delivery Vehicles in Microfluidics
Keyword
NSERC
Application summary
The loading of certain therapeutics into lipid- or polymer-based drug delivery vehicles is critical to theirsuccessful administration. Drug delivery vehicles increase efficacy for both water-soluble (e.g. the anticancer drug doxorubicin) and water-insoluble (e.g. the anticancer drug paclitaxel) drugs by controlling release and optimizing dosage over a long period of time, or by targeting specific tissues where high dosages are required. Critical figures of merit for drug delivery systems are: 1) the shape, size, and size uniformity of drug carriers, which have a strong effect on circulation times and bio-distribution, and 2) the loading levels and efficiencies for various drug types. In partnership with Northern Lipids Inc and Cardiome Pharma Corp, the proposed work will develop new microfluidic manufacturing platforms for the formation and loading of block copolymer-based drug delivery vehicles. This work leverages recent findings of the Moffitt-Sinton collaboration at the University of Victoria and the University of Toronto. The applicants discovered that localized high-shear regions within multiphase reactors promote particle break-up in addition to morphology changes, providing a new ""top-down"" handle for controlling self-assembly in microfluidic systems. The microfluidic systems to be developed here will incorporate these high shear forces in combination with fast mixing and tailored drug injection strategies, to enable simultaneous self-assembly and loading of block copolymer-based drug delivery vehicles. The approach is expected to provide improved control over shape, size, size uniformity, and drug loading, leading to increased health benefits at lower cost. This proposal addresses the ""Manufacturing"" strategic target area, and most specifically the research topic ""(a) Material Systems"". Within that topic, this work focuses on a unique intersection of chemical (self-assembly) and microfluidic (shear, mixing) production control, in order to enable new manufacturing processes for drug delivery nanomaterials with improved functional performance. An important output of the project is the training of highly qualified personnel for the pharmaceutical, instrumentation, and microsystems sectors.